Inloggad som:
MK-2870-005
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
MK-2870-005
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants with Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice in Participants with Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
PLACEHOLDER
Randomisering mellan MK2870 eller läkaren val till patienter med endometriecancer som har återfall efter både platinumbaserad cytostatika och immunterapi
Mer information om studien för vårdgivare